{"title":"2010年世界癌症靶向治疗大会第二部分。2010年9月21日至23日，瑞士苏黎世。","authors":"Hagop Youssoufian","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The Targeted Cancer Therapies World Congress, held in Zurich, included topics covering new regulatory and therapeutic developments in the field of cancer therapy and accompanying diagnostics. This conference report highlights selected presentations on improving market access, minimizing redundant R&D investment and standardizing cancer biomarkers, incorporating diagnostics into drug development and advances in biomarker discovery for cancer.</p>","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"13 12","pages":"833-5"},"PeriodicalIF":0.0000,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Targeted Cancer Therapies World Congress 2010--part 2. 21-23 September 2010, Zurich, Switzerland.\",\"authors\":\"Hagop Youssoufian\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The Targeted Cancer Therapies World Congress, held in Zurich, included topics covering new regulatory and therapeutic developments in the field of cancer therapy and accompanying diagnostics. This conference report highlights selected presentations on improving market access, minimizing redundant R&D investment and standardizing cancer biomarkers, incorporating diagnostics into drug development and advances in biomarker discovery for cancer.</p>\",\"PeriodicalId\":55031,\"journal\":{\"name\":\"Idrugs\",\"volume\":\"13 12\",\"pages\":\"833-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idrugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Targeted Cancer Therapies World Congress 2010--part 2. 21-23 September 2010, Zurich, Switzerland.
The Targeted Cancer Therapies World Congress, held in Zurich, included topics covering new regulatory and therapeutic developments in the field of cancer therapy and accompanying diagnostics. This conference report highlights selected presentations on improving market access, minimizing redundant R&D investment and standardizing cancer biomarkers, incorporating diagnostics into drug development and advances in biomarker discovery for cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
